AIDS.GOV | SERVICE LOCATOR | SEARCH

BLOG.AIDS.GOV

MENU

Research

PrEP Topics Examined at CROI 2014

Ronald Valdiserri

Among the many issues being discussed by the scientists, providers, and advocates gathered at the 2014 Conference on Retroviruses and Opportunistic Infections (CROI)  in Boston this week is pre-exposure prophylaxis (PrEP) for HIV. In a number of clinical trials, daily oral PrEP has been proven to be an effective biomedical intervention for reducing the risk…

Conversations from CROI 2014: CDC’s Dr. Jonathan Mermin

video screenshot

While at the 2014 Conference on Retroviruses and Opportunistic Infections (CROI) this week, I was pleased to sit down with Dr. Jonathan Mermin, Director of CDC’s Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP). Given that the HIV care continuum has been a topic of significant interest here at the conference, Dr. Mermin…

NIH’s Dr. Carl Dieffenbach Shares Highlights from CROI 2014 – March 4

Carl Dieffenbach at CROI

Yesterday, March 4, was the first full day of the 2014 Conference on Retroviruses and Opportunistic Infections (CROI)  in Boston. Over 4,000 HIV/AIDS research leaders from 85 countries are gathered at the annual scientific meeting discussing their work to understand, prevent, and treat HIV/AIDS and related infectious diseases. We’ve invited our colleague Dr. Carl Dieffenbach to…

NIH Seeks Input on HIV Cure Research Priorities

nih logo

The National Institutes of Health (NIH) is asking the scientific community to weigh in on what should be the highest priority research areas related to understanding HIV persistence and investigating strategies for eradicating or controlling remaining virus despite optimal antiretroviral treatment. Responses will be accepted through March 14 and will help guide the HIV Cure Initiative, a $100 million…

Scientific Advances in HIV and Viral Hepatitis To Be Examined This Week at CROI

CROI logo

The 21st Conference on Retroviruses and Opportunistic Infections (CROI)  takes place this week in Boston. This annual scientific meeting of the world’s leading researchers working to understand, prevent, and treat HIV/AIDS and related infectious diseases provides a vital forum for translating laboratory and clinical research into progress against these diseases. More than 4,000 HIV/AIDS research leaders…

Sharpening Our Focus on Black MSM Vital to Meeting National Goals

CDC Pie Chart

As we observe National Black HIV/AIDS Awareness Day (NBHAAD) 2014, we are reminded that African Americans face the most severe burden of HIV/AIDS in the United States. Among African Americans, gay, bisexual and other men who have sex with men (Black MSM) are especially hard hit, representing more than half of all estimated new HIV infections…

MEDIA AVAILABILITY: Durable End to AIDS Will Require HIV Vaccine Development

NIAID

Recent Scientific Advances Offer Promising Areas for Further Exploration   WHAT: Broader global access to lifesaving antiretroviral therapies and wider implementation of proven HIV prevention strategies could potentially control and perhaps end the HIV/AIDS pandemic. However, a safe and at least moderately effective HIV vaccine is needed to reach this goal more expeditiously and in…

Scientists Discover Hepatitis C Virus Can Remain Infectious Outside of the Body for Up to 6 Weeks

Ronald Valdiserri

A recent study by researchers from the Yale Schools of Medicine and Public Health revealed that the hepatitis C virus (HCV) can remain infectious for up to 6 weeks on surfaces at room temperature—resulting in a much longer period for potential transmission than was previously appreciated.  Prior to this study, scientists believed that HCV could…

Page 4 of 21« First...3456...1020...Last »